MedTrace Logo

Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients

NCT06490731 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2026-05-07

No results posted yet for this study

Summary

Inflammatory response and hemodynamic response in patients with intraabdominal sepsis and Effects of Dexmedetomidine versus ketamine on it .

Conditions

  • Haemodynamic Rebound

Interventions

DRUG

Dexmedetomidine

Patients will receive dexmedetomidine

DRUG

Ketamine

patients Will receive ketamine

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Principal Investigators

  • Ahmed Ismail Abdel Sabour, MD · NewValley University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-06-01
Completion
2026-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06490731 on ClinicalTrials.gov